Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression

被引:17
|
作者
Selhorst, Philippe [1 ]
Combrinck, Carina [1 ]
Ndabambi, Nonkululeko [1 ]
Ismail, Sherazaan D. [1 ]
Abrahams, Melissa-Rose [1 ]
Lacerda, Miguel [2 ]
Samsunder, Natasha [3 ]
Garrett, Nigel [3 ]
Karim, Quarraisha Abdool [3 ,4 ]
Karim, Salim S. Abdool [3 ,4 ]
Williamson, Carolyn [1 ,3 ,5 ]
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, Dept Pathol, Cape Town, South Africa
[2] Univ Cape Town, Fac Sci, Dept Stat Sci, Cape Town, South Africa
[3] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Durban, South Africa
[4] Columbia Univ, Dept Epidemiol, New York, NY USA
[5] Natl Hlth Lab Serv, Johannesburg, South Africa
关键词
HIV; replication capacity; acute infection; disease progression; tenofovir; CAPRISA; 004; infectivity; isolates; heterosexual transmission; pathogenesis; VIRAL-LOAD; TYPE-1; REPLICATION; TENOFOVIR GEL; MAJOR DETERMINANT; SEX-DIFFERENCES; GAG-PROTEASE; TRANSMISSION; IMPACT; FITNESS; NEF;
D O I
10.1128/JVI.01806-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The viral genotype has been shown to play an important role in HIV pathogenesis following transmission. However, the viral phenotypic properties that contribute to disease progression remain unclear. Most studies have been limited to the evaluation of Gag function in the context of a recombinant virus backbone. Using this approach, important biological information may be lost, making the evaluation of viruses obtained during acute infection, representing the transmitted virus, a more biologically relevant model. Here, we evaluate the roles of viral infectivity and the replication capacity of viruses from acute infection in disease progression in women who seroconverted in the CAPRISA 004 tenofovir microbicide trial. We show that viral replication capacity, but not viral infectivity, correlates with the set point viral load (Spearman r = 0.346; P = 0.045) and that replication capacity (hazard ratio [HR] = 4.52; P = 0.01) can predict CD4 decline independently of the viral load (HR = 2.9; P = 0.004) or protective HLA alleles (HR = 0.61; P = 0.36). We further demonstrate that Gag-Pro is not the main driver of this association, suggesting that additional properties of the transmitted virus play a role in disease progression. Finally, we find that although viruses from the tenofovir arm were 2-fold less infectious, they replicated at rates similar to those of viruses from the placebo arm. This indicates that the use of tenofovir gel did not select for viral variants with higher replication capacity. Overall, this study supports a strong influence of the replication capacity in acute infection on disease progression, potentially driven by interaction of multiple genes rather than a dominant role of the major structural gene gag. IMPORTANCE HIV disease progression is known to differ between individuals, and defining which fraction of this variation can be attributed to the virus is important both clinically and epidemiologically. In this study, we show that the replication capacity of viruses isolated during acute infection predicts subsequent disease progression and drives CD4 decline independently of the viral load. This provides further support for the hypothesis that the replication capacity of the transmitted virus determines the initial damage to the immune system, setting the pace for later disease progression. However, we did not find evidence that the major structural gene gag drives this correlation, highlighting the importance of other genes in determining disease progression.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] HIV-1 pol replication capacity predicts disease progression
    Daar, ES
    Kesler, KL
    Wrin, T
    Petropoulo, CJ
    Bates, M
    Lail, A
    Hellmann, NS
    Gomperts, E
    Donfield, S
    AIDS, 2005, 19 (09) : 871 - 877
  • [2] Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression
    Roberts, Lindi
    Passmore, Jo-Ann S.
    Williamson, Carolyn
    Little, Francesca
    Bebell, Lisa M.
    Mlisana, Koleka
    Burgers, Wendy A.
    van Loggerenberg, Francois
    Walzl, Gerhard
    Siawaya, Joel F. Djoba
    Karim, Quarraisha Abdool
    Karim, Salim S. Abdool
    AIDS, 2010, 24 (06) : 819 - 831
  • [3] The Interplay Between Replication Capacity of HIV-1 and Surrogate Markers of Disease
    Rindler, Audrey E.
    Kusejko, Katharina
    Kuster, Herbert
    Neumann, Kathrin
    Leemann, Christine
    Zeeb, Marius
    Chaudron, Sandra E.
    Braun, Dominique L.
    Kouyos, Roger D.
    Metzner, Karin J.
    Gunthard, Huldrych F.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (06) : 1057 - 1068
  • [4] Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression
    Kiguoya, Marion W.
    Mann, Jaclyn K.
    Chopera, Denis
    Gounder, Kamini
    Lee, Guinevere Q.
    Hunt, Peter W.
    Martin, Jeffrey N.
    Ball, T. Blake
    Kimani, Joshua
    Brumme, Zabrina L.
    Brockman, Mark A.
    Ndung'u, Thumbi
    JOURNAL OF VIROLOGY, 2017, 91 (13)
  • [5] Influence of Gag-Protease-Mediated Replication Capacity on Disease Progression in Individuals Recently Infected with HIV-1 Subtype C
    Wright, Jaclyn K.
    Novitsky, Vladimir
    Brockman, Mark A.
    Brumme, Zabrina L.
    Brumme, Chanson J.
    Carlson, Jonathan M.
    Heckerman, David
    Wang, Bingxia
    Losina, Elena
    Leshwedi, Mopo
    van der Stok, Mary
    Maphumulo, Lungile
    Mkhwanazi, Nompumelelo
    Chonco, Fundisiwe
    Goulder, Philip J. R.
    Essex, Max
    Walker, Bruce D.
    Ndung'u, Thumbi
    JOURNAL OF VIROLOGY, 2011, 85 (08) : 3996 - 4006
  • [6] HIV Replication Capacity Is an Independent Predictor of Disease Progression in Persons With Untreated Chronic HIV Infection
    Goetz, Matthew Bidwell
    Leduc, Robert
    Wyman, Nicole
    Kostman, Jay R.
    Labriola, Ann M.
    Lie, Yolanda
    Weidler, Jodi
    Coakley, Eoin
    Bates, Michael
    Luskin-Hawk, Roberta
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 (04) : 472 - 479
  • [7] Expression of HSPA14 in patients with acute HIV-1 infection and its effect on HIV-1 replication
    Bi, Mingyuan
    Kang, Wen
    Sun, Yongtao
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Evaluation of the Predictive Potential of the Short Acute Retroviral Syndrome Severity Score for HIV-1 Disease Progression in Individuals With Acute HIV Infection
    Hoenigl, Martin
    Braun, Dominique L.
    Kouyos, Roger
    Guenthard, Huldrych F.
    Little, Susan J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 (04) : E114 - E117
  • [9] HIV Type 1 Polymerase Gene Polymorphisms Are Associated With Phenotypic Differences in Replication Capacity and Disease Progression
    Ng, Oon Tek
    Laeyendecker, Oliver
    Redd, Andrew D.
    Munshaw, Supriya
    Grabowski, Mary K.
    Paquet, Agnes C.
    Evans, Mark C.
    Haddad, Mojgan
    Huang, Wei
    Robb, Merlin L.
    Reynolds, Steven J.
    Gray, Ronald H.
    Wawer, Maria J.
    Serwadda, David
    Eshleman, Susan H.
    Quinn, Thomas C.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (01) : 66 - 73
  • [10] Immune Correlates of Disease Progression in Linked HIV-1 Infection
    Tuen, Michael
    Bimela, Jude S.
    Bonin, Andrew N.
    Ding, Shilei
    Harkins, Gordon W.
    Weiss, Svenja
    Itri, Vincenza
    Durhams, Allison R.
    Porcella, Stephen F.
    Soni, Sonal
    Mayr, Luzia
    Meli, Josephine
    Torimiro, Judith N.
    Tango, Marcel
    Wang, Xiaohong
    Kong, Xiang-Peng
    Nadas, Arthur
    Kaufmann, Daniel E.
    Brumme, Zabrina L.
    Nanfack, Aubin J.
    Quinn, Thomas C.
    Zolla-Pazner, Susan
    Redd, Andrew D.
    Finzi, Andres
    Gorny, Miroslaw K.
    Nyambim, Phillipe N.
    Duerr, Ralf
    FRONTIERS IN IMMUNOLOGY, 2019, 10